Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

Eli Lilly HQ

Lilly nears EU approval of arthritis drug baricitinib

On course for early 2017 verdict, setting up challenge to Pfizer’s Xeljanz

- PMLiVE

Making a list and checking it twice…

The promise of mobile health lies not in recording information but in promoting behaviour change

- PMLiVE

Asceneuron appoints chief medical officer

Novartis’ Michael Ryan joins the neurodegenerative diseases specialist

Former Astellas regulatory lead joins Oxular

Robert Waters becomes regulatory affairs VP

Roche Basel Switzerland

Genentech names Anderson new CEO as Ian Clark retires

Leadership changes come as the Roche subsidiary faces increasing biologics competition

Sanofi reception

Lilly and Boehringer launch first Lantus clone Basaglar in US

Starts biosimilar at 15% discount to Sanofi’s basal insulin product

- PMLiVE

The CRM journey: linking CRM to revenue in pharma

A great CRM demands a clear vision and objective for operational efficiency and commercial effectiveness

- PMLiVE

UK Dementia Research Institute names director

Prof Bart De Strooper to lead the national institute

- PMLiVE

AZ’s Kelly Teasdale moves to Burson-Marsteller

She joins its UK healthcare practice as a senior director

- PMLiVE

FDA green light for Pfizer’s eczema drug

Blockbuster-hopeful Eucrisa expected to launch early next year at $580 per 60mg tube

- PMLiVE

Intercept gets EU nod for rare liver disease therapy

Ocaliva approved as a combination treatment for primary biliary cholangitis

Lucid logo

Medical communications that improve outcomes and value to patients

In 2017, Lucid aims to advance its approach to measuring the impact of its behaviour-change programmes, building on the existing evidence-base to develop new approaches to capturing metrics on value...

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links